Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New T-Cell therapy aims to fight Hard-to-Treat prostate cancer

NCT ID NCT07164443

Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 28, 2026 · Updated 7 times

Summary

This phase 3 study tests a drug called pasritamig, which helps the body's immune T-cells attack prostate cancer cells. The trial includes 663 men with metastatic castration-resistant prostate cancer, a stage where standard hormone therapy no longer works. Participants receive either pasritamig plus best supportive care or a placebo plus best supportive care, and researchers will compare how long they live.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pasritamig (a T-cell redirecting agent)
What this could lead to
If successful, this could provide a new treatment option that extends survival for men with advanced prostate cancer that has stopped responding to hormone therapy.
What could go wrong
This is a large phase 3 trial, but the drug is still experimental. It may not improve survival compared to placebo, and side effects from T-cell activation can be serious.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,203 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Histologically confirmed adenocarcinoma of the prostate * Metastatic castration-resistant prostate cancer (mCRPC): Disease that is metastatic either to bone, any lymph node, or both without clear evidence of other metastatic sites at the time of screening by conventional imaging with computed tomography (CT) or magnetic resonance imaging (MRI) (chest, abdomen, and pelvis) and 99m\^Tc bone scan. Visceral disease is not allowed * PSA greater than or equal to (≥) 2 nanogram per milliliter (ng/mL) at screening * In the opinion of the investigator, the next best treatment option is a clinical trial * Participants are required to have had all life-prolonging therapies for which they are clinically eligible in the opinion of the investigator and to which they have access. Prior therapies could have been given in any disease setting (not limited to mCRPC). In particular, prior treatment specifications include receipt of the following: Androgen-receptor pathway inhibitor (ARPI): Must have progressed on at least 1 ARPI and unlikely to benefit from retreatment with another ARPI Taxanes: Required to have received at least 2 previous taxane-based regimens. If a participant has received only 1 taxane regimen, the participant is eligible if: 1. Cabazitaxel is not available 2. The participant's physician deems the participant unsuitable to receive a second taxane regimen due to toxicity risk or prior intolerance Note: a taxane-based regimen consists of at least 2 cycles of a taxane (either as a single agent or in combination with other therapies) administered within the same 2-month period Radioligand therapy: Required to have been previously treated with at least 1 dose of Prostate-specific membrane antigen (PSMA)-targeted lutetium radioligand therapy (eg, lutetium Lu-177 vipivotide tetraxetan), unless one of the following applies: 1. PSMA-targeted lutetium radioligand therapy is unavailable, not accessible, or not clinically indicated. 2. The participant's physician deems the participant unsuitable to receive PSMA-targeted lutetium radioligand therapy. Polyadenosine diphosphate-ribose polymerase inhibitors (PARPi): Required to have been previously treated with PARPi, if the participant has a known germline or somatic BRCA mutation and treatment is available * Prior orchiectomy or medical castration (receiving ongoing ADT with a GnRH analog \[agonist or antagonist\]) prior to the first dose of study treatment and must continue this therapy throughout the treatment phase * Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 * Participants are eligible if they have the following values: A) eGFR ≥ 40 milliliters per minute (mL/min) B) Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) less than or equal to (≤) 3 times the Upper Limit of Normal (ULN) C) Total bilirubin \<1.5 times ULN D) Absolute neutrophil count (ANC) ≥ 1.0x10\^9/per liter (L) E) Hemoglobin ≥ 8.0 grams per deciliter (g/dL) F) Platelet count ≥ 75x10\^9/L Exclusion Criteria * Venous thromboembolic events within 1 month prior to the first dose of study treatment; uncomplicated (Grade ≤ 2) deep vein thrombosis is not exclusionary * Active autoimmune disease within the past 12 months that requires systemic immunosuppressive medications (eg, chronic corticosteroid, methotrexate, or tacrolimus) * Participants with Grade 1 or higher fever (≥38ºC) or active infection requiring systemic treatment within 7 days prior to randomization are ineligible. Participants must be afebrile (\<38ºC) at the time of study treatment dosing unless approved by medical monitor * Clinically significant pulmonary compromise, particularly a requirement for supplemental oxygen use (\>2 liters per minute (L/min) by nasal cannula) to maintain adequate oxygenation * Prior or concurrent second malignancy (other than the disease under study) for which natural history or treatment could likely interfere with any study endpoints of safety or the efficacy of the study treatment(s) * Any of the following within 6 months prior to first dose of study treatment: A) Myocardial infarction B) Severe or unstable angina C) Clinically significant ventricular arrhythmias D) Congestive heart failure (New York Heart Association class II to IV) E) Transient ischemic attack F) Cerebrovascular accident \- Prior treatment with any CD3-directed therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metastatic castration resistant prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma Prostatic Neoplasms, Castration-Resistant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metastatic castration-resistant prostate neoplasms Metastatic castration-resistant prostatic neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    171 sites in 17 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.O.U. Citta della Salute e della Scienza di Torino - Presidio Molinette

    RECRUITING

    Torino, 10126, Italy

  • AZ Maria Middelares

    RECRUITING

    Ghent, 9000, Belgium

  • AZ Sint-Jan

    RECRUITING

    Bruges, 8000, Belgium

  • Arthur J E Child Comprehensive Cancer Centre

    RECRUITING

    Calgary, Alberta, T2N 5G2, Canada

  • Asan Medical Center

    RECRUITING

    Seoul, 05505, South Korea

  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

  • Az Groeninge

    RECRUITING

    Kortrijk, 8500, Belgium

  • Azienda Di Rilievo Nazionale E Di Alta Specializzazione

    RECRUITING

    Palermo, 90127, Italy

  • Azienda Ospedaliera Universitaria Federico II

    RECRUITING

    Naples, 80131, Italy

  • BC Cancer Vancouver

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Bay Pines VA Healthcare System

    RECRUITING

    Bay Pines, Florida, 33744, United States

  • Blue Ridge Cancer Care

    RECRUITING

    Roanoke, Virginia, 24014, United States

  • CHC MontLegia

    RECRUITING

    Liège, 4000, Belgium

  • CHRU Brest - Hopital Morvan

    RECRUITING

    Brest, 29200, France

  • CHU Lyon Sud

    RECRUITING

    Pierre-Bénite, 69495, France

  • CHU de Quebec Universite Laval

    RECRUITING

    Québec, Quebec, G1J 1Z4, Canada

  • Canisius-Wilhelmina ZH

    RECRUITING

    Nijmegen, 6532 SZ, Netherlands

  • Carolina Urologic Research Center

    RECRUITING

    Myrtle Beach, South Carolina, 29572, United States

  • Cedars Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

  • Centre Georges Francois Leclerc

    RECRUITING

    Dijon, 21000, France

  • Centre Leon Berard

    RECRUITING

    Lyon, 69008, France

  • Centre Oscar Lambret

    RECRUITING

    Lille, 59000, France

  • Chang Gung Memorial Hospital

    RECRUITING

    Kaohsiung City, 833, Taiwan

  • Chongqing University Cancer Hospital

    RECRUITING

    Chongqing, 400030, China

  • Chonnam National University Hwasun Hospital

    RECRUITING

    Hwasungun, 58128, South Korea

  • Chu Helora Hospital La Louviere Site Jolimont

    RECRUITING

    La Louvière, 7100, Belgium

  • Chungnam National University Hospital

    RECRUITING

    Daejeon, 35015, South Korea

  • Clinique Saint Pierre

    RECRUITING

    Ottignies, 1340, Belgium

  • Cliniques Universitaires Saint Luc

    RECRUITING

    Brussels, 1200, Belgium

  • Colorado Clinical Research

    RECRUITING

    Lakewood, Colorado, 80228, United States

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

  • Compass Oncology

    COMPLETED

    Portland, Oregon, 97227, United States

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • East Jefferson General Hospital

    RECRUITING

    Metairie, Louisiana, 70006, United States

  • Erasmus MC

    RECRUITING

    Rotterdam, 3015 GD, Netherlands

  • Fiona Stanley Hospital

    RECRUITING

    Murdoch, 6150, Australia

  • Florida Cancer Specialists & Research Institute

    RECRUITING

    Fort Myers, Florida, 33901, United States

  • Fondazione IRCCS Istituto Nazionale dei Tumori

    RECRUITING

    Milan, 20133, Italy

  • Fondazione Policlinico Universitario A Gemelli IRCCS

    RECRUITING

    Roma, 00168, Italy

  • Fred Hutchinson Cancer Research Center

    RECRUITING

    Seattle, Washington, 98109, United States

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, 200032, China

  • Fundacao Antonio Prudente A C Camargo Cancer Center

    RECRUITING

    São Paulo, 01509 900, Brazil

  • Ghent University Hospital

    RECRUITING

    Ghent, 9000, Belgium

  • Gibbs Cancer Center

    RECRUITING

    Spartanburg, South Carolina, 29303, United States

  • Gibbs Cancer Center and Research Institute Pelham

    RECRUITING

    Greer, South Carolina, 29650, United States

  • Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina

    RECRUITING

    Florianópolis, 88020 210, Brazil

  • Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

  • Hartford Hospital

    RECRUITING

    Hartford, Connecticut, 06102, United States

  • Henry Ford Cancer Detroit

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Hopital Saint Joseph

    RECRUITING

    Paris, 75014, France

  • Hopitaux universitaires de Strasbourg

    RECRUITING

    Strasbourg, 672098, France

  • Hosp Univ Vall D Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Hosp Virgen de La Victoria

    RECRUITING

    Málaga, 29010, Spain

  • Hosp. Univ. 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hosp. Univ. Ramon Y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Hosp. de Jerez de La Frontera

    RECRUITING

    Jerez de la Frontera, 11407, Spain

  • Hospital Moinhos de Vento

    RECRUITING

    Porto Alegre, 90035-001, Brazil

  • I.C.O. Rene Gauducheau

    RECRUITING

    Saint-Herblain, 44805, France

  • ICON Cancer Care

    RECRUITING

    Kurralta Park, 5037, Australia

  • IN VIVO Sp. z o.o

    RECRUITING

    Bydgoszcz, 85 048, Poland

  • IOV IRCCS Padova

    RECRUITING

    Padova, 35128, Italy

  • Institut Bergonie

    RECRUITING

    Bordeaux, 33000, France

  • Institut de Cancerologie de Lorraine

    RECRUITING

    Vandœuvre-lès-Nancy, 54519, France

  • Institute of Science Tokyo Hospital

    RECRUITING

    Bunkyō City, 113 8519, Japan

  • Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia

    RECRUITING

    Joinville, 89201 260, Brazil

  • Isala Kliniek

    RECRUITING

    Zwolle, 8025 AB, Netherlands

  • Istituto Clinico Humanitas

    RECRUITING

    Rozzano, 20089, Italy

  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20016, United States

  • Johns Hopkins University

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Kanazawa University Hospital

    RECRUITING

    Kanazawa, 920 8641, Japan

  • Keystone Urology Specialists

    RECRUITING

    Lancaster, Pennsylvania, 17601, United States

  • Klinikum Nuernberg Nord

    RECRUITING

    Nuremberg, 90419, Germany

  • Klinikum rechts der Isar der TU Muenchen

    RECRUITING

    München, 81675, Germany

  • Kobe University Hospital

    RECRUITING

    Kobe, 650 0017, Japan

  • Krankenhaus NorthWest

    RECRUITING

    Frankfurt am Main, 60488, Germany

  • Kyushu University Hospital

    RECRUITING

    Fukuoka, 812 8582, Japan

  • Lakeridge Health

    RECRUITING

    Oshawa, Ontario, L1G2B9, Canada

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Liga Norte Riograndense Contra O Cancer

    RECRUITING

    Natal, 59062 000, Brazil

  • Linkou Chang Gung Memorial Hospital

    RECRUITING

    Taoyuan, 333, Taiwan

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Maastricht UMC

    RECRUITING

    Maastricht, 6229 HX, Netherlands

  • Martini Ziekenhuis

    RECRUITING

    Groningen, 9728NT, Netherlands

  • Martini-Klinik am UKE GmbH

    RECRUITING

    Hamburg, 20246, Germany

  • Michael E DeBakey VA Medical Center

    RECRUITING

    Houston, Texas, 77030, United States

  • MidLantic Urology

    RECRUITING

    Bala-Cynwyd, Pennsylvania, 19004, United States

  • Mission Cancer Blood

    RECRUITING

    Waukee, Iowa, 50263, United States

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • NYU Langone Health Laura and Isaac Perlmutter Cancer Center

    RECRUITING

    New York, New York, 10016, United States

  • NYU Langone Hospital Long Island

    RECRUITING

    Mineola, New York, 11501, United States

  • NYU Langone Hospitals

    RECRUITING

    Brooklyn, New York, 11220, United States

  • Nanjing Drum Tower Hospital

    RECRUITING

    Nanjing, 210008, China

  • Nantong Tumor Hospital

    RECRUITING

    Nantong, 226300, China

  • Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy

    RECRUITING

    Warsaw, 02 781, Poland

  • National Cancer Center

    RECRUITING

    Goyang-si, 10408, South Korea

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, 277 8577, Japan

  • National Hospital Organization Shikoku Cancer Center

    RECRUITING

    Matsuyama, 791-0280, Japan

  • National Hospital Organization Tokyo Medical Center

    RECRUITING

    Meguro Ku, 152 8902, Japan

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 100, Taiwan

  • Oregon Urology Institute

    RECRUITING

    Springfield, Oregon, 97477, United States

  • Ospedali Riuniti Foggia

    RECRUITING

    Foggia, 71122, Italy

  • Pan American Center for Oncology Trials LLC

    RECRUITING

    Rio Piedras, 00935, Puerto Rico

  • Peking University First Hospital

    RECRUITING

    Beijing, 100034, China

  • Penn Medicine Abramson Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, 3000, Australia

  • Princess Alexandra Hospital

    RECRUITING

    Woolloongabba, 4102, Australia

  • Princess Margaret Hospital

    RECRUITING

    Toronto, Ontario, M5G 2C1, Canada

  • Puerto Rico Medical Research Center

    RECRUITING

    San Juan, 00917, Puerto Rico

  • Ralph H Johnson Veterans Hospital

    RECRUITING

    Charleston, South Carolina, 29401, United States

  • Reinier de Graaf Gasthuis

    RECRUITING

    Delft, 2625 AD, Netherlands

  • Rocky Mountain Cancer Centers

    RECRUITING

    Aurora, Colorado, 80012, United States

  • Ronald Reagan UCLA Medical Center

    RECRUITING

    Los Angeles, California, 90095, United States

  • Royal Marsden Hospital (Sutton)

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

  • Saitama Medical University International Medical Center

    RECRUITING

    Hidaka, 350 1298, Japan

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • San Francisco VA Medical Center

    RECRUITING

    San Francisco, California, 94121, United States

  • Severance Hospital Yonsei University Health System

    RECRUITING

    Seoul, 03722, South Korea

  • Spaarne Gasthuis

    RECRUITING

    Hoofddorp, 2134 TM, Netherlands

  • Staedtisches Klinikum Braunschweig

    RECRUITING

    Braunschweig, 38126 DE, Germany

  • Studienpraxis Urologie Nurtingen

    RECRUITING

    Nürtingen, 72622, Germany

  • Sun Yat Sen University Cancer Center

    RECRUITING

    Guangzhou, 510060, China

  • Sunnybrook Health Sciences Center

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

  • Szpital Grochowski Im Dr Med Rafala Masztaka Sp Z O O

    RECRUITING

    Warsaw, 04 073, Poland

  • Szpital Wojewodzki im Mikolaja Kopernika w Koszalinie

    RECRUITING

    Koszalin, 75-581, Poland

  • Taichung Veterans General Hospital

    RECRUITING

    Taichung, 40705, Taiwan

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, 112, Taiwan

  • Tennessee Oncology - Chattanooga

    RECRUITING

    Chattanooga, Tennessee, 37404, United States

  • Tennessee Oncology Nashville

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Tergooi

    RECRUITING

    Hilversum, 1212 VG, Netherlands

  • Texas Oncology West Texas

    RECRUITING

    Wichita Falls, Texas, 76310, United States

  • The Catholic University of Korea Seoul St Marys Hospital

    RECRUITING

    Seoul, 06591, South Korea

  • The Christie NHS Foundation Trust Christie Hospital

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • The First Affiliated Hospital of Guangxi Medical University

    RECRUITING

    Nanning, 530021, China

  • The First Affiliated Hospital of Ningbo University

    RECRUITING

    Ningbo, 315010, China

  • The First Affiliated Hospital of Wenzhou Medical University

    RECRUITING

    Wenzhou, 325000, China

  • The First Affiliated Hospital of Xian Jiaotong University

    RECRUITING

    Xi'an, 710061, China

  • The First Bethune Hospital of Jilin University

    RECRUITING

    Changchun, 130021, China

  • The Second Hospital Of Tianjin Medical University

    RECRUITING

    Tianjin, 300211, China

  • The Third People's Hospital of Chengdu

    RECRUITING

    Chengdu, 500643, China

  • Toho University Sakura Medical Center

    RECRUITING

    Sakura, 285-8741, Japan

  • Tungs' Taichung MetroHarbor Hospital

    RECRUITING

    Taichung, 435, Taiwan

  • UPMC Cancer Centers

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

  • Universitaetsklinikum Duesseldorf

    RECRUITING

    Düsseldorf, 40225, Germany

  • Universitaetsklinikum Essen

    RECRUITING

    Essen, 45147, Germany

  • Universitaetsklinikum Heidelberg Nationales Centrum fuer Tumorerkrankungen

    RECRUITING

    Heidelberg, 69120, Germany

  • Universitaetsklinikum Muenster

    RECRUITING

    Münster, 48149, Germany

  • University College London Hospitals

    RECRUITING

    London, WC1E 6BT, United Kingdom

  • University Hospital of Cleveland

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • University Hospitals Birmingham NHS Foundation Trust

    RECRUITING

    Birmingham, B15 2TH, United Kingdom

  • University Of Minnesota Medical Center

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

  • University of California at San Diego

    RECRUITING

    La Jolla, California, 92093, United States

  • University of Cincinnati

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of Colorado Cancer Center

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Iowa Hospital and Clinics

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Michigan Health System

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • University of Washington

    RECRUITING

    Seattle, Washington, 98195, United States

  • Uniwersytecki Szpital Kliniczny w Bialymstoku

    RECRUITING

    Bialystok, 15 276, Poland

  • Urologicum Duisburg

    RECRUITING

    Duisburg, 47169, Germany

  • Urology Clinics of North Texas

    COMPLETED

    Dallas, Texas, 75231, United States

  • Utah Cancer Specialists

    RECRUITING

    Salt Lake City, Utah, 84106, United States

  • VA Portland Health Care System

    RECRUITING

    Portland, Oregon, 97239, United States

  • VA Puget Sound Healthcare System

    RECRUITING

    Seattle, Washington, 98108, United States

  • Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Virginia Oncology Associates

    RECRUITING

    Norfolk, Virginia, 23502, United States

  • Warringal Private Hospital

    RECRUITING

    Heidelberg, 3084, Australia

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, 610041, China

  • XCancer Omaha / Urology Cancer Center

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • Yokohama City University Hospital

    RECRUITING

    Yokohama, 236 0004, Japan

  • Yokohama City University Medical Center

    RECRUITING

    Yokohama, 232 0024, Japan

  • Yokosuka Kyosai Hospital

    RECRUITING

    Yokosuka, 238 8558, Japan

  • ZAS Augustinus

    RECRUITING

    Wilrijk, 2610, Belgium

  • Zhongnan Hospital Wu Han University

    RECRUITING

    Wuhan, 430071, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.